Effect of Yoga Breathing Exercises Versus Aerobic Exercise on Hematological Parameters

The Effect of Yoga Breathing Exercises Versus Aerobic Exercise on Hematological Parameters in Iron Deficiency Anemic Females

Is there effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females?

The purpose of the study is to investigate the effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females

Study Overview

• Status: Recruiting
• Conditions: Iron Deficiency Anemia
• Intervention / Treatment: Other: Yuga; Other: Aerobic exercises

Detailed Description

60 patients with iron deficiency anemia and will receive medical treatment of anemia and Dietary advice for 12 weeks . thirty patient from the 60 patients will receive yoga therapy and 50 minutes yoga therapy 6 days a week for 12 weeks while the other 30 patients will receive aerobic exercise for 12 weeks

• Study Type: Interventional
• Enrollment (Estimated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ali MA Ismail; Phone Number: 01005154209; Email: ali.mohamed@pt.cu.edu.eg
• Study Contact Backup: Name: Ali MA Ismail, Phd; Phone Number: 01005154209; Email: ali.mohamed@pt.cu.edu.eg

Study Locations

• Egypt
  • Giza, Egypt
    • Recruiting
    • October 6 University
    • Contact: Shokry Ms Youssef, Ass lecturer; Phone Number: 01008111991; Email: drshokry2015@gmail.com
    • Contact: Hossam Mh Metwaly, Lecturer; Phone Number: 01112730605; Email: hosammagdy40@yahoo.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Sixty female patients referred with iron deficiency anemia
2. Their age will be ranged from 30-40 years old.
3. All patients have a history of anemia.
4. All patients should be medically stable.
5. The body mass index (BMI) ranged from 25:29.9 Kg/m2
6. Number of parity not exceed 3 times.
7. Period of menses from 3-5 days

Exclusion Criteria:

1. Patients with cognitive impairments.
2. All types of anemia except iron deficiency anemia
3. patients with hearing problems.
4. patients with Diabetes, Hypertension.
5. Patients with Musculoskeletal, Neurological, Cardiovascular and Respiratory problems
6. patients with mental problems.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group (I); consists of 30 patients with iron deficiency anemia and will receive medical treatment of anemia, Dietary advices and 50 minutes yoga therapy 6 days a week for 12 weeks	Other: Yuga; Traditional yoga body posture for 15 minutes, yoga breathing exercises for 30 minutes and meditation for 5 minutes for 12 weeks
Other: Group (II); consists of 30 patients with iron deficiency anemia and will receive medical treatment for anemia, Diet advices and 30 minutes of aerobic exercises in form of treadmill according to the target exercise heart rate for 12 weeks.	Other: Aerobic exercises; in form of treadmill according to the target exercise heart rate for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
serum iron level	it will be measured in serum from complete blood picture. Reference range from 50 till 212 ug/dl. Number of participants are 60 females.	it will be measured after 12 weeks
ferritin level	it will be measured in serum from iron profile. Reference range from 10 till 158 ng/ml. Number of participants are 60 females.	it will be measured after 12 weeks
iron binding capacity level	it will be measured in serum from iron profile. Reference range from 250 till 400 ug/dl. Number of participants are 60 females.	it will be measured after 12 weeks
count of red blood cells	it will be measured in serum from complete blood picture. Reference range from 3.80 till 4.80 million cell/cmm. Number of participants are 60 females.	it will be measured after 12 weeks
Hemoglobin level	it will be measured in serum from complete blood . picture. Reference range from 12 till 15 g/dl. Number of participants are 60 females.	it will be measured after 12 weeks
hematocrite level	it will be measured in serum from complete blood picture. Reference range from 36% till 45%. Number of participants are 60 females.	it will be measured after 12 weeks
lymphocytes level	it will be measured in serum from differential white cell count. Reference range absolute from 1000 till 4000 and relative from 20% till 45%. Number of participants are 60 females.	it will be measured after 12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
six minute walking distance	The six minute walking distance is measured using six Minute Walk Test which is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity. The tools are used include 30 meters corridor,2 cones,stopwatch,chair,mechanical lap counter and sphygmomanometer Number of participants are 60 females.	it will be measured after 12 weeks
The fatigue severity scale(FSS)	The FSS questionnaire contains nine statements that rate the severity of your fatigue symptoms. Read each statement and circle a number from 1 to 7, based on how accurately it reflects your condition during the past week and the extent to which you agree or disagree that the statement applies to you. A total score of less than 36 suggests that you may not be suffering from fatigue. A total score of 36 or more suggests that you may need further evaluation by a physician. Number of participants are 60 females.	it will be measured after 12 weeks

Collaborators and Investigators

• Sponsor: Shokry Mahmoud Youssef Mohamed
• Investigators: Principal Investigator: shoukry MA youssef, ass lecturer, 6 october University

Study record dates

Study Major Dates

• Study Start (Actual): July 17, 2023
• Primary Completion (Estimated): December 1, 2023
• Study Completion (Estimated): December 30, 2023

Study Registration Dates

• First Submitted: June 27, 2023
• First Submitted That Met QC Criteria: July 17, 2023
• First Posted (Actual): July 18, 2023

Study Record Updates

• Last Update Posted (Actual): August 29, 2023
• Last Update Submitted That Met QC Criteria: August 27, 2023
• Last Verified: July 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Metabolic Diseases; Hematologic Diseases; Anemia, Hypochromic; Anemia; Iron Metabolism Disorders; Anemia, Iron-Deficiency; Iron Deficiencies
• Other Study ID Numbers: P.T.REC/012/004556

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No